Circulating and tissue BATF2 mRNA can serve as a multipurpose biomarker capable of the diagnosis, prognosis prediction, efficacy evaluation, and recurrence monitoring in NPC. This evidence concerns the gene BATF2 and nasopharyngeal carcinoma.